One pharma stock with great domestic brand potential but prices have not moved thus far.
Long only once price crosses 204 with a SL below 197. (Reason being id rather buy above 200EMA than right now even though now would be lower risk/reward)
INDOCO has demonstrated bullish RSI divergence on weekly chart. RSI is making higher highs while prices have remained range bound. 195-201 is good accumulation zone for initial target of 240. Once RSI closes above 50, then stock likely to see further upside.
